• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒病抗原检测的应用:影响疾病传播可能性预测的因素。

Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission.

机构信息

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.

Department of Respirology, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.

出版信息

Int J Infect Dis. 2021 Mar;104:65-72. doi: 10.1016/j.ijid.2020.12.079. Epub 2021 Jan 2.

DOI:10.1016/j.ijid.2020.12.079
PMID:33401037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7778366/
Abstract

OBJECTIVES

Rapid antigen testing (RAT) for coronavirus disease 2019 (COVID-19) has lower sensitivity but high accuracy during the early stage when compared to reverse transcription quantitative polymerase chain reaction (RT-qPCR). The aim of this study was to investigate the concordance between RAT and RT-qPCR results, and their prediction of disease transmission.

METHODS

This single-center retrospective observational study of inpatients with COVID-19 was conducted from March 6 to June 14, 2020. Nasopharyngeal swabs were used to perform RAT and RT-qPCR. The primary endpoint was concordance between RAT and RT-qPCR results. The secondary endpoints were the factors causing disagreement in the results and the estimated transmissibility in RT-qPCR-positive patients with mild symptoms.

RESULTS

Overall, 229 samples in viral transport medium (VTM) were obtained from 105 patients. The positive and negative concordance rates for VTM were 41% vs 99% (κ = 0.37) and 72% vs 100% (κ = 0.50) for samples collected on disease days 2-9. An increased body temperature (odds ratio 0.54) and absence of drugs with potential antiviral effect (odds ratio 0.48) yielded conflicting results. RAT was associated with the ability to end isolation (OR 0.11, 95% confidence interval 0.20-0.61).

CONCLUSIONS

RAT and RT-qPCR results were highly consistent for samples collected at the appropriate time and could be useful for inferring the possibility of transmissibility.

摘要

目的

与逆转录定量聚合酶链反应(RT-qPCR)相比,用于 2019 年冠状病毒病(COVID-19)的快速抗原检测(RAT)在早期具有较低的敏感性但具有较高的准确性。本研究旨在调查 RAT 与 RT-qPCR 结果的一致性及其对疾病传播的预测。

方法

这是一项针对 COVID-19 住院患者的单中心回顾性观察研究,于 2020 年 3 月 6 日至 6 月 14 日进行。使用鼻咽拭子进行 RAT 和 RT-qPCR。主要终点是 RAT 与 RT-qPCR 结果的一致性。次要终点是导致结果不一致的因素以及 RT-qPCR 阳性轻症患者的估计传染性。

结果

总体而言,从 105 名患者中获得了 229 份病毒转运培养基(VTM)样本。在疾病第 2-9 天采集的样本中,VTM 的阳性和阴性一致性率分别为 41%与 99%(κ=0.37)和 72%与 100%(κ=0.50)。体温升高(比值比 0.54)和无潜在抗病毒作用的药物(比值比 0.48)会导致结果不一致。RAT 与隔离结束的能力相关(OR 0.11,95%置信区间 0.20-0.61)。

结论

在适当的时间采集样本时,RAT 与 RT-qPCR 结果高度一致,可用于推断传染性的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2502/7778366/23f19ebd6287/mmc5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2502/7778366/188ddbc7257c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2502/7778366/e292be06f431/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2502/7778366/23f19ebd6287/mmc5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2502/7778366/188ddbc7257c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2502/7778366/e292be06f431/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2502/7778366/23f19ebd6287/mmc5_lrg.jpg

相似文献

1
Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission.新型冠状病毒病抗原检测的应用:影响疾病传播可能性预测的因素。
Int J Infect Dis. 2021 Mar;104:65-72. doi: 10.1016/j.ijid.2020.12.079. Epub 2021 Jan 2.
2
Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.采用 RT-qPCR、FilmArray 呼吸道Panel v2.1 和抗原检测对持续性病毒脱落感染 SARS-CoV-2 的患者进行分析。
J Infect Chemother. 2021 Feb;27(2):406-409. doi: 10.1016/j.jiac.2020.10.026. Epub 2020 Oct 29.
3
Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.1033 例患者 1308 份鼻咽拭子的前瞻性研究:LUMIPULSE SARS-CoV-2 抗原检测与 RT-qPCR 的比较。
Int J Infect Dis. 2021 Apr;105:7-14. doi: 10.1016/j.ijid.2021.02.005. Epub 2021 Feb 5.
4
Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.快速 SARS-CoV-2 抗原检测有助于 COVID-19 疾病的早期诊断。
Biosci Trends. 2021 May 11;15(2):93-99. doi: 10.5582/bst.2021.01090. Epub 2021 Mar 26.
5
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.Panbio 抗原快速检测在症状出现后 7 天内对诊断 SARS-CoV-2 感染是可靠的。
J Clin Virol. 2020 Dec;133:104659. doi: 10.1016/j.jcv.2020.104659. Epub 2020 Oct 16.
6
The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.从 RT-PCR 咽拭子检测阴性的患者向他人传播 SARS-CoV-2 的可能性:两起新冠肺炎暴发的聚集性疫情。
Jpn J Infect Dis. 2020 Nov 24;73(6):399-403. doi: 10.7883/yoken.JJID.2020.165. Epub 2020 May 29.
7
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.核衣壳蛋白抗原快速检测在 SARS-CoV-2 感染诊断中的准确性。
Clin Microbiol Infect. 2021 Feb;27(2):289.e1-289.e4. doi: 10.1016/j.cmi.2020.09.057. Epub 2020 Oct 5.
8
[Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].[对疑似SARS-CoV-2感染进行微生物学检测的重复:基于临床概率的评分的效用]
Rev Esp Quimioter. 2020 Dec;33(6):410-414. doi: 10.37201/req/080.2020. Epub 2020 Sep 11.
9
[Retrospective analysis of the performance of the SARS-CoV-2 rapid antigen detection test compared to the reference RT-PCR test].[严重急性呼吸综合征冠状病毒2型快速抗原检测试验与参考逆转录聚合酶链反应试验性能的回顾性分析]
Ann Biol Clin (Paris). 2021 Apr 1;79(2):168-175. doi: 10.1684/abc.2021.1641.
10
Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.快速抗原检测试验在 COVID-19 诊断中的一线检测性能不佳。
J Clin Virol. 2020 Aug;129:104455. doi: 10.1016/j.jcv.2020.104455. Epub 2020 May 21.

引用本文的文献

1
Evaluation and Clinical Validation of Guanidine-Based Inactivation Transport Medium for Preservation of SARS-CoV-2.基于胍的新冠病毒灭活转运培养基用于保存严重急性呼吸综合征冠状病毒2的评估及临床验证
Adv Pharmacol Pharm Sci. 2022 Jul 21;2022:1677621. doi: 10.1155/2022/1677621. eCollection 2022.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
Performance of Antigen Detection Tests for SARS-CoV-2: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Immunochromatographic test for the detection of SARS-CoV-2 in saliva.免疫层析试验检测唾液中的 SARS-CoV-2。
J Infect Chemother. 2021 Feb;27(2):384-386. doi: 10.1016/j.jiac.2020.11.016. Epub 2020 Dec 23.
2
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity.新型冠状病毒长期RNA脱落及其与IgG血清阳性的时间关联。
Cell Death Discov. 2020 Dec 2;6(1):138. doi: 10.1038/s41420-020-00375-y.
3
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.新冠病毒感染轻症与重症患者的系统性及黏膜性抗体对 SARS-CoV-2 的应答特征。
新型冠状病毒抗原检测试验的性能:系统评价与荟萃分析
Diagnostics (Basel). 2022 Jun 4;12(6):1388. doi: 10.3390/diagnostics12061388.
4
ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2.ESCMID COVID-19 指南:SARS-CoV-2 的检测。
Clin Microbiol Infect. 2022 Jun;28(6):812-822. doi: 10.1016/j.cmi.2022.02.011. Epub 2022 Feb 23.
5
Factors that Influence the Reported Sensitivity of Rapid Antigen Testing for SARS-CoV-2.影响新冠病毒快速抗原检测报告敏感性的因素。
Front Microbiol. 2021 Oct 5;12:714242. doi: 10.3389/fmicb.2021.714242. eCollection 2021.
6
Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.新型 SARS-CoV-2 抗原快速诊断准确性的系统评价和荟萃分析。
PLoS Med. 2021 Aug 12;18(8):e1003735. doi: 10.1371/journal.pmed.1003735. eCollection 2021 Aug.
7
Microbiological Testing for Coronavirus Disease 2019.2019年冠状病毒病的微生物检测
JMA J. 2021 Apr 15;4(2):67-75. doi: 10.31662/jmaj.2021-0012. Epub 2021 Apr 2.
J Allergy Clin Immunol. 2021 Feb;147(2):545-557.e9. doi: 10.1016/j.jaci.2020.10.040. Epub 2020 Nov 20.
4
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)感染持续时间:何时可以安全解除隔离?
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.
5
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.2020 年 1 月至 5 月期间,英国 COVID-19 病例的传染性持续时间及其与 RT-PCR 循环阈值的相关性。
Euro Surveill. 2020 Aug;25(32). doi: 10.2807/1560-7917.ES.2020.25.32.2001483.
6
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.四种自动化免疫分析和三种 ELISA 评估针对 SARS-CoV-2 刺突蛋白和核蛋白的抗体反应。
Clin Microbiol Infect. 2020 Nov;26(11):1557.e1-1557.e7. doi: 10.1016/j.cmi.2020.07.038. Epub 2020 Jul 31.
7
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.严重急性呼吸综合征冠状病毒 2 感染患者长期病毒排出的临床特征及相关因素:一项单中心 28 天研究。
J Infect Dis. 2020 Aug 17;222(6):910-918. doi: 10.1093/infdis/jiaa388.
8
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'.Vo' 镇暴发的 SARS-CoV-2 疫情得到控制。
Nature. 2020 Aug;584(7821):425-429. doi: 10.1038/s41586-020-2488-1. Epub 2020 Jun 30.
9
Evaluation of rapid antigen test for detection of SARS-CoV-2 virus.SARS-CoV-2 病毒快速抗原检测评估。
J Clin Virol. 2020 Aug;129:104500. doi: 10.1016/j.jcv.2020.104500. Epub 2020 Jun 8.
10
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19.美国传染病学会关于新冠病毒病诊断的指南
Clin Infect Dis. 2020 Jun 16. doi: 10.1093/cid/ciaa760.